These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6281114)

  • 21. [Clinical study of a new cephalosporin ceftriaxone (Ro 13-9904) in sepsis and other infectious forms of particular severity].
    Calonghi GF; Vezzani F
    G Ital Chemioter; 1981; 28(1-2):55-9. PubMed ID: 6290304
    [No Abstract]   [Full Text] [Related]  

  • 22. [Penetration of cefotaxime into bronchial secretions].
    Bergogne-Berezin E; Morel C; Pierre J; Monrocq N; Dournovo P; Benard Y
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):501-5. PubMed ID: 6289226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of cefotaxime for the treatment of common infections: in vitro, pharmacokinetic and clinical considerations.
    Wilson WR; Bouza E; Lode H; Mouton Y
    J Chemother; 1997 May; 9 Suppl 2():5-18. PubMed ID: 9248972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cefoperazone--a new cephalosporin antibiotic with broader spectrum of activity].
    Jendroschek T; Belmega G; Lode H; Kemmerich B; Dzwillo G; Koeppe P; Wagner J
    Med Klin; 1981 Feb; 76(4):102-6, 70. PubMed ID: 6452567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical experience with cefotaxime with particular reference to septicaemia.
    McKendrick MW
    Ir Med J; 1982 May; 75(5 Suppl):8-9. PubMed ID: 6284677
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of lincomycin in infectious respiratory pathology].
    Saad H
    Tunis Med; 1966; 44(6):387 passim. PubMed ID: 5984102
    [No Abstract]   [Full Text] [Related]  

  • 27. [Kinetic and clinical studies on a new cephalosporin: Cefotiam].
    Soranzo ML; Capra E; Eandi M; Bosio G; Salassa B; Bendiscioli L; Bramato C; Musso E; Andreoni G; Morelli B; Fabiano A; Di Nola F; Misto P
    Minerva Med; 1982 Oct; 73(39):2671-8. PubMed ID: 6289193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefotaxime in a single daily dose in lower urinary tract infections.
    Peralta S; Affronti M; Malta R; Delle Vedove G; Pirrotta P; Rotondo G; Paternostro D; Rini GB; Di Rosa S
    J Chemother; 1989 Jul; 1(4 Suppl):847-8. PubMed ID: 16312666
    [No Abstract]   [Full Text] [Related]  

  • 29. [Infections in childhood; from respiratory infections to tropical medicine].
    Fortschr Med Suppl; 1993; 144():1-8. PubMed ID: 9260316
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical experience in the treatment of bacterial bronchopneumopathy with cefotaxime].
    Montanari S; Roca A; Pasqua F; Gramiccioni E
    Clin Ter; 1983 Apr; 105(2):119-24. PubMed ID: 6305552
    [No Abstract]   [Full Text] [Related]  

  • 31. [A comparative study between cefminox (MT-141) and cefotaxime in respiratory tract infections].
    Miki F; Inoue E; Teragaki M; Akioka K; Yoshiyama M; Hiraga T; Murata T; Saito A; Ujiie A; Abe M
    Kansenshogaku Zasshi; 1985 Feb; 59(2):115-63. PubMed ID: 3925035
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cefditoren pivoxil: A new oral cephalosporin for skin, soft tissue and respiratory tract infections].
    Hernández-Martin J; Romá E; Salavert M; Doménech L; Poveda JL
    Rev Esp Quimioter; 2006 Sep; 19(3):231-46. PubMed ID: 17099791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Report of experiences with the oral cephalosporin-derivative cephaclor in respiratory tract infections].
    Spath P
    Wien Med Wochenschr; 1983 Jan; 133(1):27-30. PubMed ID: 6837048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A new cephalosporinic derivative: cephaloglycin. Clinical experience with 100 patients].
    Mazzei CM; Lasala FG; Gherardi CG; Rechniewski C
    Rev Clin Esp; 1969 Jul; 114(1):11-24. PubMed ID: 5820911
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cefminox versus cefotaxime in the treatment of complicated urinary tract infection].
    Gastón de Iriarte E; Cárcamo Valor P; Diez-Enciso M; Prieto Prieto J; Pérez Balcabao I; Gimeno del Sol M; Coronel Granado P; Morán Soto MJ
    Actas Urol Esp; 1995 Sep; 19(8):635-41. PubMed ID: 8669331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experience with the third generation cephalosporins, cefoperazone and cefotaxime: report.
    Reddy J
    N Z Med J; 1984 May; 97(755):293-6. PubMed ID: 6328390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical experience and microbiological results with rondomycin in diseases of the respiratory tract].
    Bamberg H; Schliewen C
    Dtsch Med J; 1966 Sep; 17(18):533-6. PubMed ID: 5918016
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical study of a new cephalosporin: ceftriaxone (RO 13-9904) in resurgent acute and chronic bronchopneumopathies].
    Pezza A; Giacomelli P; Montella R; Casino G
    Arch Monaldi; 1983; 38(1-2):17-24. PubMed ID: 6326701
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pharmacokinetics and clinical studies of a new cephalosporin: cefamandole nafate].
    Di Nola F; Eandi M; Capra E; Soranzo ML; Bosio G; Bramato C; Salassa B; Andrini L; Robecchi GA
    Minerva Med; 1980 May; 71(21):1515-24. PubMed ID: 7383410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Activity and tolerance of cefotaxime in complex urinary infections].
    Altieri A; Màsala A
    Minerva Urol; 1983; 35(2):141-8. PubMed ID: 6314111
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.